Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval. your-feed-science, White House Coronavirus Outbreak (2020), Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Eli Lilly and Company, Food and Drug Administration, Regeneron Pharmaceuticals Inc, Trump, Donald J